Source: ClinicalTrials.gov
Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
View on ClinicalTrials.govCitation record
- Study start
- 2026-05-15
- NCT number
- NCT07574723
- Overall status
- Recruiting
- Study type
- Interventional
- Lead sponsor
- Dasman Diabetes Institute
- Enrollment
- 68 participants
- Conditions
- Obesity
- Interventions
- Tirzepatide (Per-label titration) (Drug) · Tirzepatide (Flexible titration) (Drug)
- Last updated at source
- 20 Oct 2026
- Original source
- https://clinicaltrials.gov/study/NCT07574723
This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.